BLADDER UROTHELIAL CARCINOMA
Clinical trials for BLADDER UROTHELIAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new BLADDER UROTHELIAL CARCINOMA trials appear
Sign up with your email to follow new studies for BLADDER UROTHELIAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Bladder cancer radiation doses tested in safety study
Disease control CompletedThis study tested the safety of combining different doses of external radiation therapy with the chemotherapy drug gemcitabine in 19 bladder cancer patients. The goal was to find the highest safe dose of radiation that can be given alongside chemo. Participants had early-stage bl…
Matched conditions: BLADDER UROTHELIAL CARCINOMA
Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Engineered T-Cells take aim at bladder, skin, and head and neck cancers
Disease control CompletedThis early-phase study tested whether genetically modified T-cells (MAGE-A10ᶜ⁷⁹⁶T) are safe for people with advanced urothelial cancer, melanoma, or head and neck cancer. Ten participants received their own engineered immune cells after chemotherapy. The main goal was to check fo…
Matched conditions: BLADDER UROTHELIAL CARCINOMA
Phase: PHASE1 • Sponsor: Adaptimmune • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC